Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30184
Study of Peptide Fragment of Alpha-Fetoprotein as a Radionuclide Vehicle

Authors: Alesya Ya. Maruk, Olga E. Klementyeva, Ekaterina I. Lesik, Anton A. Larenkov, Alexander B. Bruskin

Abstract:

Alpfa-fetoprotein and its fragments may be an important vehicle for targeted delivery of radionuclides to the tumor. We investigated the effect of conditions on the labeling of biologically active synthetic peptide based on the (F-afp) with technetium-99m. The influence of the nature of the buffer solution, pH, concentration of reductant, concentration of the peptide and the reaction temperature on the yield of labeling was examined. As a result, the following optimal conditions for labeling of (F-afp) are found: pH 8.5 (phosphate and bicarbonate buffers) and pH from 1.7 to 7.0 (citrate buffer). The reaction proceeds with sufficient yield at room temperature for 30 min at the concentration of SnCl2 and (Fafp) (F-afp) is to be less than 10 mkg/ml and 25 mkg/ml, respectively. Investigations of the test drug accumulation in the tumor cells of human breast cancer were carried out. Results can be assumed that the in vivo study of the (F-afp) in experimental tumor lesions will show concentrations sufficient for imaging these lesions by SPECT.

Keywords: peptide, technetium-99m, tumor, SPECT.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1074561

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1277

References:


[1] Guide to the experimental (preclinical) study of new pharmacological substances, R.U.Habriev, Ed. Moscow, 2005.
[2] The State Pharmacopoeia of the Russian Federation: Part 1. OFS 42- 0061-07. Publishing "Scientific Centre of Medical Products"- 12 ed. - 2008 - 704 sec. - S. 150.
[3] The State Pharmacopoeia of the Russian Federation: Part 1. OFS 42- 0061-07. Publishing "Scientific Centre of Medical Products"- 12 ed. - 2008 - 704 sec. - S. 125.